학술논문
614P Tolerance and preliminary efficacy of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with advanced ovarian carcinoma: A phase I study with expansion cohort (ICONIC)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S825-S825
Subject
Language
ISSN
0923-7534